Cargando…
Sarecycline: a narrow spectrum tetracycline for the treatment of moderate-to-severe acne vulgaris
Sarecycline is a novel, narrow-spectrum, once-daily tetracycline-derived oral antibiotic that is FDA-approved in the US to be taken with or without food for moderate-to-severe acne vulgaris for ages 9 years of age and older. Sarecycline possesses anti-inflammatory properties and potent activity agai...
Autores principales: | Moore, Angela Yen, Charles, Jean Elizze M, Moore, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6802708/ https://www.ncbi.nlm.nih.gov/pubmed/31475868 http://dx.doi.org/10.2217/fmb-2019-0199 |
Ejemplares similares
-
Microbiological Profile of Sarecycline, a Novel Targeted Spectrum Tetracycline for the Treatment of Acne Vulgaris
por: Zhanel, George, et al.
Publicado: (2018) -
Effect of Sarecycline on the Acne Symptom and Impact Scale and Concerns in Moderate-to-Severe Truncal Acne in Open-Label Pilot Study
por: Moore, Angela Yen, et al.
Publicado: (2023) -
Sarecycline treatment for acne vulgaris: Rationale for weight‐based dosing and limited impact of food intake on clinical efficacy
por: Grada, Ayman, et al.
Publicado: (2021) -
Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut Microbiota
por: Moura, Ines B., et al.
Publicado: (2022) -
Reduced blood-brain barrier penetration of acne vulgaris antibiotic sarecycline compared to minocycline corresponds with lower lipophilicity
por: Grada, Ayman, et al.
Publicado: (2022)